Structural Models of the Prescription Drug Market

2019 ◽  
Author(s):  
Andrew T. Ching ◽  
Manuel Ignacio Hermosilla ◽  
Qiang Liu
Keyword(s):  
Prescription Drug ◽  
Structural Models ◽  
Drug Market ◽  
Prescription Drug Market

scholarly journals Structural Models of the Prescription Drug Market

2019 ◽  
Vol 12 (4) ◽  
pp. 1-76
Author(s):  
Andrew T. Ching ◽  
Manuel Hermosilla ◽  
Qiang Liu
Keyword(s):  
Prescription Drug ◽  
Structural Models ◽  
Drug Market ◽  
Prescription Drug Market

scholarly journals PHP27 INFLATION: PRESCRIPTION DRUG MARKET BASKET DEFINITION AND THEIR IMPACT

2004 ◽  
Vol 7 (3) ◽  
pp. 375
Author(s):  
DS Hutchins ◽  
DS Hutchins
Keyword(s):  
Prescription Drug ◽  
Drug Market ◽  
Market Basket ◽  
Prescription Drug Market

The generic competition paradox in a universal healthcare's prescription drug market

2015 ◽  
Vol 14 (4) ◽  
pp. 438
Author(s):  
Kenichi Ohkita ◽  
Kazumitsu Minamikawa
Keyword(s):  
Prescription Drug ◽  
Drug Market ◽  
Generic Competition ◽  
Prescription Drug Market

scholarly journals Common Agent or Double Agent? Pharmacy Benefit Managers in the Prescription Drug Market

2021 ◽  
Author(s):  
Rena Conti ◽  
Brigham Frandsen ◽  
Michael Powell ◽  
James Rebitzer
Keyword(s):  
Prescription Drug ◽  
Drug Market ◽  
Pharmacy Benefit ◽  
Double Agent ◽  
Prescription Drug Market

The Prescription Drug Market

2021 ◽  
pp. 14-37
Author(s):  
Neumann Peter J. ◽  
Cohen Joshua T. ◽  
Ollendorf Daniel A
Keyword(s):  
Health Insurance ◽  
Prescription Drug ◽  
Drug Market ◽  
Supply Side ◽  
Drug Markets ◽  
Demand Side ◽  
Considerable Uncertainty ◽  
Pricing Power ◽  
Prescription Drug Market ◽  
System Feature

This chapter describes how prescription drug markets deviate from “normal” competitive markets. On the demand side, there is considerable uncertainty in disease prognosis and treatment effects; buyers have much less information than sellers; consumers usually do not pay directly for their prescriptions but rather have health insurance, which protects them from a drug’s full price; and physicians and insurers play a major role in consumer choices. On the supply side, firms are heavily regulated, subject to laws requiring that drugs undergo extensive testing before entering the marketplace. Monopolies are a system feature, designed to incentivize companies to invest in expensive and risky drug discovery by providing the prospect of a big payoff if the investment succeeds. Patents and market exclusivity restrict competition and provide drug developers considerable pricing power. The challenge for policymakers is how to achieve reasonable or fair drug prices in light of these market distortions.

scholarly journals Demand Effects of Recent Changes in Prescription Drug Promotion

2003 ◽  
Vol 6 (1) ◽  
Author(s):  
Meredith B. Rosenthal ◽  
Ernst R. Berndt ◽  
Julie M. Donohue ◽  
Arnold M. Epstein ◽  
Richard G. Frank
Keyword(s):  
Prescription Drug ◽  
Drug Market ◽  
Drug Spending ◽  
Direct To Consumer ◽  
On Demand ◽  
Therapeutic Class ◽  
Drug Promotion ◽  
Prescription Drug Spending ◽  
Direct To Consumer Advertising ◽  
Prescription Drug Market

The release of clarified Food and Drug Administration (FDA) guidelines and independent changes in consumer behavior provide an opportunity to study the effects of direct-to-consumer advertising (DTCA) in the prescription drug market alongside the effects of various physician-oriented promotions. We examine the effects of DTCA and detailing for brands in five therapeutic classes of drugs, using monthly aggregate U.S. data from August 1996 through December 1999. In terms of impact of DTCA on demand, we provide evidence on two issues: (1) do increases in DTCA increase the market size of an entire therapeutic class? and (2) does DTCA increase within-class market share of advertised drugs? Our findings suggest that, for these classes of drugs, DTCA has been effective primarily through increasing the size of the entire class. Overall, we estimate that 13 to 22 percent of the recent growth in prescription drug spending is attributable to the effects of DTCA.

scholarly journals Changing Medicare’s Protected Classes: History, Mistrust, and Budgets in the Prescription Drug Market

2019 ◽  
Vol 70 (10) ◽  
pp. 858-859 ◽  
Author(s):  
Richard G. Frank
Keyword(s):  
Prescription Drug ◽  
Drug Market ◽  
Prescription Drug Market

Advertising in Response to Entry: An Empirical Analysis of the Prescription Drug Market

2006 ◽  
Author(s):  
Winghan Jackie Kwong ◽  
Edward C. Norton
Keyword(s):  
Prescription Drug ◽  
Empirical Analysis ◽  
Drug Market ◽  
Prescription Drug Market
Sign in / Sign up

Export Citation Format

Share Document